A future where cancer isn’t just treated, but cured

Innovations in medicines are striving ahead and will improve standards of care for those diagnosed with cancers, such as Triple Negative Breast Cancer, which accounts for about 1 in every 8 breast cancers. Through innovation, we can deepen our understanding of triple negative breast cancer and ultimately cure patients.

Breakthrough innovations happening now, in areas like oncology, will transform the lives of patients in the future.

In this short video, hear insights from cancer survivor and CEO of The Marie Keating Foundation Liz Yeates and Professor Janice Walshe, Medical Oncologist on why progress is important in treating TNBC.